These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. Jing Y, Kong Y, Hou X, Liu H, Fu Q, Jiao Z, Peng H, Wei X. J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546 [Abstract] [Full Text] [Related]
6. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients. Wang XH, Shao K, An HM, Zhai XH, Zhou PJ, Chen B. Eur J Clin Pharmacol; 2022 Aug; 78(8):1261-1272. PubMed ID: 35536394 [Abstract] [Full Text] [Related]
7. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients. Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E. Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354 [Abstract] [Full Text] [Related]
13. Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients. Yildirim E, Şahin G, Kaltuş Z, Çolak E. Clin Lab; 2019 Nov 01; 65(11):. PubMed ID: 31710427 [Abstract] [Full Text] [Related]
14. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model. Huang L, Liu Y, Jiao Z, Wang J, Fang L, Mao J. Eur J Pharm Sci; 2020 Feb 15; 143():105199. PubMed ID: 31862313 [Abstract] [Full Text] [Related]
15. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation. Yang JW, Liao SS, Zhu LQ, Zhao Y, Zhang Y, Sun XY, Rao W, Qu W, Li WZ, Sun LY. Int J Clin Pharmacol Ther; 2015 Jan 15; 53(1):75-83. PubMed ID: 25207550 [Abstract] [Full Text] [Related]
16. The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation. de Wildt SN, van Schaik RH, Soldin OP, Soldin SJ, Brojeni PY, van der Heiden IP, Parshuram C, Nulman I, Koren G. Eur J Clin Pharmacol; 2011 Dec 15; 67(12):1231-41. PubMed ID: 21698374 [Abstract] [Full Text] [Related]
19. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome. Li L, Zhu M, Li DY, Guo HL, Hu YH, Xu ZY, Jing X, Chen F, Zhao F, Li YM, Xu J, Jiao Z. Int Immunopharmacol; 2021 Sep 15; 98():107827. PubMed ID: 34284341 [Abstract] [Full Text] [Related]